financetom
Business
financetom
/
Business
/
Enovix Shares Are Trading Lower Thursday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enovix Shares Are Trading Lower Thursday: What's Going On?
Sep 11, 2025 9:34 AM

Enovix Corporation ( ENVX ) shares are trading lower Thursday after the company announced a $300 million convertible notes offering.

What To Know:Enovix ( ENVX ) priced $300 million aggregate principal amount of 4.75% convertible senior notes due 2030 in a private placement to qualified institutional buyers. The company also granted purchasers an option to buy up to an additional $60 million of notes. The offering is expected to close on Sept. 15, subject to customary conditions.

Enovix ( ENVX ) estimates net proceeds of about $290.4 million, or $348.6 million if the option is exercised in full. The company expects to use about $37.7 million of the proceeds to fund capped call transactions designed to offset potential dilution from the conversion of the notes. The remaining proceeds are earmarked for general corporate purposes, which may include acquisitions.

The notes will initially be convertible into cash, shares of Enovix ( ENVX ) common stock or a combination of both at Enovix's ( ENVX ) election, at an initial conversion price of about $11.21 per share. This represents a premium of roughly 22.5% to the last reported sale price of Enovix ( ENVX ) stock on Sept. 10.

Related Link: Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

ENVX Price Action: At the time of publication, Enovix ( ENVX ) shares are trading 12.75% lower at $7.98, according to data from Benzinga Pro.

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck's Investigational Drug in Treatment-Naive Adults with HIV-1 Infection Shows Primary Efficacy
Merck's Investigational Drug in Treatment-Naive Adults with HIV-1 Infection Shows Primary Efficacy
Nov 19, 2025
07:37 AM EST, 11/19/2025 (MT Newswires) -- Merck ( MRK ) said Wednesday the pivotal phase 3 trial of its investigational regimen of doravirine/islatravir in treatment-naive adults with HIV-1 infection met its success criterion of primary efficacy. Trial topline results showed the non-inferiority of the drug and a comparable safety profile to once-daily oral bictegravir/emtricitabine/tenofovir alafenamide, Merck ( MRK )...
TJX Q3 revenue beats estimates
TJX Q3 revenue beats estimates
Nov 19, 2025
Overview * TJX Q3 FY26 revenue grows 7% yr/yr, beating analyst expectations * Q3 diluted EPS rises 12% to $1.28, exceeding company plan * Company returned $1.1 bln to shareholders via buybacks and dividends in Q3 Outlook * Company expects Q4 comp sales to rise 2% to 3% * TJX raises full-year EPS outlook to $4.63-$4.66 * Company plans $2.5...
TJ Maxx parent TJX raises annual profit forecast
TJ Maxx parent TJX raises annual profit forecast
Nov 19, 2025
(Reuters) -TJX Cos ( TJX ) raised annual profit forecast on Wednesday, anticipating that broad sourcing strategy and seasonal inventory will attract bargain-hunting shoppers to its off-price stores. Shares of the company rose about 3% in premarket trading. They have risen nearly 21% so far this year. The Framingham, Massachusetts-based company has capitalized on a seasonal shift from late-summer to...
Dana, Allison Transmission Receive Regulatory Approvals for Off-Highway Business Deal
Dana, Allison Transmission Receive Regulatory Approvals for Off-Highway Business Deal
Nov 19, 2025
07:38 AM EST, 11/19/2025 (MT Newswires) -- Dana (DAN) and Allison Transmission ( ALSN ) said Wednesday they have received all required regulatory approvals for the previously announced sale of Dana's off-highway business to Allison. The transaction is expected to close at or near the year-end, the companies said. The transaction has enabled Dana to return $600 million to shareholders...
Copyright 2023-2026 - www.financetom.com All Rights Reserved